| abstract |
The invention provides an antiepileptic drug composition, comprising the following components, calculated in parts by weight: 5-8 parts of cannabidiol; 1-1.5 parts of paracannabinoids; 0.4-0.8 parts of limonene; 0.1-0.5 parts of nerolidol 0.1-0.3 part of myrcene; 0.1-0.4 part of linalool; 0.05-0.2 part of terpineol, prepared by the following method, including the following steps: S1: take the cannabidiol obtained in claim 1 and dissolve it in pure In water, the cannabidiol extract is obtained; S2: the cannabidiol extract is mixed with THC, paracannabinoid, limonene, nerolidol, myrcene, linalool and terpineol in proportion to obtain formula solution; S3: filter the formula solution obtained in S2 by micron sterilization, for subsequent use; S4: add water-soluble sodium citrate, flavoring agent, essence and purified water to S3 to obtain a compound solution. |